1. Whether the Federal government infringed on Petitioner's rights under the Equal Protection Clause of the Fourteenth Amendment to the United States Constitution, made applicable to the federal statutes by the Due Process Clause of the Fifth Amendment, by creatively enforcing Controlled Substances Act (CSA) against him.

2. Whether providing prescription medications and other healthcare services under Rules and Regulations of Food and Drug Agency to impoverished blacks and other minorities to avert health disparity as determined by Congress in Minority Health and Health disparities Research and Education Act of 2000; 42 U S C 300u-6 and 21 U S C 399f of Food Drug and Cosmetic Act, is a violation of 21 U S C 842 of the Food Drug and Cosmetic Act1.

3. Whether by the Federal Government's use of "The Diversion Amendment of 1984" in the Uniform Controlled Substance Act whose provisions were covered by a latter Act, Act embraced new provisions repugnant to it, to bring a civil action against petitioner, did not violate the repeal clause of the United States Constitution.

Whether the Federal government infringed on Petitioner's rights under the Equal Protection Clause of the Fourteenth Amendment to the United States Constitution, made applicable to the federal statutes by the Due Process Clause of the Fifth Amendment, by creatively enforcing Controlled Substances Act (CSA) against him